Skip to content Skip to sidebar Skip to footer

Stringent Infection Control Measures Needed in Hertfordshire’s NHS Trust Hospitals

Alerts have been raised concerning infection control numbers falling below their expected trajectory at a Hertfordshire NHS trust, as highlighted in a recent report. Data for November 2025 shows a concerning level of hospital-acquired infections, with 42 cases reported. West Herts Teaching Hospitals NHS Trust, responsible for Watford General Hospital, St Albans City Hospital, and…

Read more

Multi-bed Hospital Rooms: A Breeding Ground for Staphylococcus Aureus Infection

Patients lodged in multi-bed hospital rooms stand a higher risk, up to nine times, of contracting Staphylococcus aureus in comparison to those in single-bed rooms. These findings were presented at a recent IDWeek. Although the elevated infection risk in multi-patient rooms is generally acknowledged within the health sector, there's been a palpable lack of supportive…

Read more

Sterility Indicators—– Paving the Future of Infection Control

According to the latest predictive market analyses, substantial expansion is anticipated for the Sterility Indicators Market, with predictions of growth from a standing of USD 1.1 billion in 2023 to an impressive USD 3.5 billion by 2033. In amplified awareness towards hospital-acquired infections (HAIs) and stringent sterilization protocols, the market finds its key growth-driving factors. Sterility…

Read more

Steriwave®: A Revolution in Preoperative Nasal Decolonization – An Independent Research Perspective by the University Hospital Zurich

The University Hospital Zurich (USZ) has recently initiated an independent, cutting-edge clinical study to assess the efficiency of Steriwave®, the antimicrobial photodynamic therapy by the Canadian company, Ondine Biomedical Inc. This is yet another significant milestone in Ondine's mission to offer innovative solutions for infection prevention and limit the growing global concern of antimicrobial resistance. Deployed…

Read more

Hospital Superbugs: Understanding the Threat and Need for Infection Prevention

Superbugs, powerful pathogens such as bacteria, viruses, and fungi, pose grave concerns within hospital environments. Their presence threatens vulnerable patients, raising the odds of serious infections and potentially fatal outcomes. In fact, in the United States alone, approximately 2.8 million infections and 35,000 annual deaths can be attributed to microbial strains resistant to multiple drugs…

Read more

Legionnaires’ Disease: A Hidden Threat Overlooked by Public Health

From a unique perspective as the former CEO of a company that provided infection surveillance software to hospitals, Adam Boris observed the impact of numerous hospital-acquired infections. However, he was startled by his recent experience with the overlooked and escalating issue of Legionnaires’ disease. There has been a rise in outbreaks, including significant cases across…

Read more

Increasing Transparency in Hospital-Acquired Infections: A Potential New Law in Missouri

In Missouri, legislators are currently considering bills that could mandate hospitals to report cases of hospital-acquired infections to state health officials. The aim of this requirement is to foster transparency about infection rates within healthcare facilities, this data would be gathered, analyzed and made available to the general public. These proposals come in response to…

Read more

Innovative Infection Control: Trinity Guardion Secures Funding for Expansion of Soteria® Bed Barrier System

Leading hospital bed hygiene solution provider, Trinity Guardion, has successfully amassed a total of $6 million, inclusive of $3.5 million from a Series B funding round. The raised capital will expedite the manufacturing and market introduction of the cutting-edge Soteria® Bed Barrier System. Established in 2010 and situated in Batesville, Indiana, Trinity Guardion pioneers the…

Read more

Proactive Therapeutics: Navigating the Global Hospital-Acquired Infections Market Growth

In a notable development in the global healthcare sector, the hospital-acquired infections (HAI) therapeutics market was valued at USD 12.5 billion in 2023. Exhibiting a promising compound annual growth rate (CAGR) of 3.2% from 2024 to 2032, the industry expansion is significantly bolstered by a rise in HAIs. Factors such as prolonged hospital stays, increased…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]